Please login to the form below

Not currently logged in
Email:
Password:

forecasting

This page shows the latest forecasting news and features for those working in and with pharma, biotech and healthcare.

Gilead’s Biktarvy gets European approval, setting up battle with GSK

Gilead’s Biktarvy gets European approval, setting up battle with GSK

Analysts predict big things for Biktarvy, forecasting revenues of around $896mn this year and $3.7bn for 2022, making long-term HIV treatment more convenient for patients, and showing itself to

Latest news

  • 2018 by Darwin 2018 by Darwin

    While we can’t predict, in the forecasting sense, we can foresee, to a limited extent, where the variation, selection and replication that lies at the heart of Darwin’s model

  • J+D expands its Asian reach J+D expands its Asian reach

    relationships with our innovative forecasting solutions will help J D continue to be the forecasting partner of choice across the globe.”. ... Seigo Maeda, founder and managing director of SDMJ consulting, said: “I believe the collaboration will

  • Reading the signals Reading the signals

    This sounds like a counsel of despair and indeed it is for traditional strategic planners who rely on forecasting alone.

  • Merck forges cancer-focused big data alliance with Palantir Merck forges cancer-focused big data alliance with Palantir

    efficacy. Finally, the two companies will collaborate on a platform that will allow improved global supply chain forecasting and help to get medicines to patients who need them around the world

  • Neurodegenerative disorders market set to reach $45bn by 2022 Neurodegenerative disorders market set to reach $45bn by 2022

    But shake-up expected from flurry of new approvals and patent expirations

More from news
Approximately 7 fully matching, plus 60 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Gamida Cell strengthens leadership team Gamida Cell strengthens leadership team

    Nee will lead market research, analytics, forecasting, commercial strategies and competitive intelligence at the company, activities he has experience with following his time with Biogen, Amgen and Novartis.

  • Joel Colwell moves from Sanofi to J+D Consulting Joel Colwell moves from Sanofi to J+D Consulting

    Previously at Sanofi, Colwell joins the firm as they prepare to launch new projects, which he will support, with a particular focus on forecasting and insight generation. ... Colwell said: “J D have some great new products that will make forecasting so

  • Astellas promotes Anthony Fiordaliso to VP, Americas finance Astellas promotes Anthony Fiordaliso to VP, Americas finance

    Astellas has promoted Anthony Fiodaliso to VP, Americas finance to oversee areas such as managerial reporting and budgeting, financial planning and analysis, and revenue forecasting.

  • Sophie Adlard joins J+D Consulting as a business analyst Sophie Adlard joins J+D Consulting as a business analyst

    market research and forecasting projects going forward.”. ... She joins at a time when the group has been focusing on forecasting training zone, face to face workshops and development of webinars.

  • Kris Barker joins J+D Consulting Kris Barker joins J+D Consulting

    He said: “The opportunity to integrate and develop my skills in forecasting is something I am really looking forward to in joining J D Consulting.”.

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Forecasting in Dynamic Oncology Markets

    Forecasting in Dynamic Oncology Markets. Anthony Woodhead, Business Development Manager for Black Swan Analysis, highlights in this article the exciting changes impacting the Oncology market and the challenges that Healthcare companies ... There are

  • NEW FROM GOWER

    NEW FROM GOWER. Arthur G. Cook's second edition of Forecasting for the Pharmaceutical Industry is now available. ... Arthur G. Cook's eagerly awaited second edition of Forecasting for the Pharmaceutical Industry is here!

  • Forecasting in Forgotten Markets

    Forecasting in Forgotten Markets. In this article, Anthony Woodhead, Business Development Manager for Black Swan Analysis, discusses the challenges facing innovators in markets like Dementia, which has attracted significant investment over

  • Maria Eletskaya joins Cello Health Insight

    With 13 years of experience in quantitative research, her key areas of specialisation are based on complex methodologies, segmentation studies, conjoint analysis, understanding behavioural drivers and barriers, brand equity, and forecasting.

  • TWO SENIOR APPOINTMENTS FOR CELLO HEALTH BIOCONSULTING

    He has particular experience in brand and portfolio strategy, life cycle planning, launch strategy and planning, forecasting and competitive gaming.

More from PMHub
Approximately 4 fully matching, plus 21 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics